Ocular Therapeutix OCUL Total Cost of Revenue
Total Cost of Revenue at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Ocular Therapeutix in its filing.
Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSold.
The official record: Ocular Therapeutix’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ocular Therapeutix's total cost of revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ocular Therapeutix's total cost of revenue?
- Ocular Therapeutix (OCUL) reported total cost of revenue of $1.33M in Q1 2026.
- How has Ocular Therapeutix's total cost of revenue changed year-over-year?
- Ocular Therapeutix's total cost of revenue increased by 5.3% year-over-year, from $1.26M to $1.33M.
- What is the long-term trend for Ocular Therapeutix's total cost of revenue?
- Over 4 years (2021 to 2025), Ocular Therapeutix's total cost of revenue has grown at a 10.5% compound annual growth rate (CAGR), from $4.41M to $6.57M.
- What does total cost of revenue mean?
- The aggregate of all direct costs attributable to producing goods and delivering services that generated the company's revenue, including materials, labor, and overhead.